Example of Prostate Cancer format
Recent searches

Example of Prostate Cancer format Example of Prostate Cancer format Example of Prostate Cancer format Example of Prostate Cancer format Example of Prostate Cancer format Example of Prostate Cancer format Example of Prostate Cancer format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Prostate Cancer format Example of Prostate Cancer format Example of Prostate Cancer format Example of Prostate Cancer format Example of Prostate Cancer format Example of Prostate Cancer format Example of Prostate Cancer format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Prostate Cancer — Template for authors

Publisher: Hindawi
Categories Rank Trend in last 3 yrs
Urology #58 of 94 down down by 37 ranks
Oncology #245 of 340 down down by 85 ranks
Cancer Research #170 of 207 down down by 44 ranks
journal-quality-icon Journal quality:
Medium
calendar-icon Last 4 years overview: 30 Published Papers | 52 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 18/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

Nature

Quality:  
High
CiteRatio: 16.0
SJR: 4.539
SNIP: 2.28
open access Open Access
recommended Recommended

American Association for Cancer Research

Quality:  
High
CiteRatio: 15.8
SJR: 4.103
SNIP: 1.983
open access Open Access
recommended Recommended

American Association for Cancer Research

Quality:  
High
CiteRatio: 18.2
SJR: 5.427
SNIP: 2.243
open access Open Access

American Association for Cancer Research

Quality:  
High
CiteRatio: 8.7
SJR: 2.273
SNIP: 1.157

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.7

64% from 2019

CiteRatio for Prostate Cancer from 2016 - 2020
Year Value
2020 1.7
2019 4.7
2018 6.1
2017 3.8
2016 1.7
graph view Graph view
table view Table view

0.377

46% from 2019

SJR for Prostate Cancer from 2016 - 2020
Year Value
2020 0.377
2019 0.703
2018 0.877
2017 0.89
2016 1.617
graph view Graph view
table view Table view

1.215

2% from 2019

SNIP for Prostate Cancer from 2016 - 2020
Year Value
2020 1.215
2019 1.191
2018 0.79
2017 0.867
2016 0.716
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has decreased by 64% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has decreased by 46% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 2% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Prostate Cancer

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Hindawi

Prostate Cancer

Prostate Cancer is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies related to all aspects of prostate cancer.... Read More

Urology

Oncology

Cancer Research

Medicine

i
Last updated on
18 Jun 2020
i
ISSN
2090-3111
i
Acceptance Rate
34%
i
Frequency
Not provided
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
unsrt
i
Citation Type
Numbered
[25]
i
Bibliography Example
C. W. J. Beenakker. “Specular andreev reflection in graphene”. Phys. Rev. Lett., vol. 97, no. 6, 067007, 2006.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1155/2013/560857
Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent
13 Feb 2013 - Prostate Cancer

Abstract:

Prostate cancer (CaP) is the leading cancer among men of African descent in the USA, Caribbean, and Sub-Saharan Africa (SSA). The estimated number of CaP deaths in SSA during 2008 was more than five times that among African Americans and is expected to double in Africa by 2030. We summarize publicly available CaP data and col... Prostate cancer (CaP) is the leading cancer among men of African descent in the USA, Caribbean, and Sub-Saharan Africa (SSA). The estimated number of CaP deaths in SSA during 2008 was more than five times that among African Americans and is expected to double in Africa by 2030. We summarize publicly available CaP data and collected data from the men of African descent and Carcinoma of the Prostate (MADCaP) Consortium and the African Caribbean Cancer Consortium (AC3) to evaluate CaP incidence and mortality in men of African descent worldwide. CaP incidence and mortality are highest in men of African descent in the USA and the Caribbean. Tumor stage and grade were highest in SSA. We report a higher proportion of T1 stage prostate tumors in countries with greater percent gross domestic product spent on health care and physicians per 100,000 persons. We also observed that regions with a higher proportion of advanced tumors reported lower mortality rates. This finding suggests that CaP is underdiagnosed and/or underreported in SSA men. Nonetheless, CaP incidence and mortality represent a significant public health problem in men of African descent around the world. read more read less
View PDF
203 Citations
open accessOpen access Journal Article DOI: 10.1155/2013/418340
The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton.
Emma Roberts1, Davina A. F. Cossigny1, Gerald M. Y. Quan1
12 Dec 2013 - Prostate Cancer

Abstract:

Despite the clinical implication and high incidence of bone and spinal metastases, the molecular mechanisms behind prostate cancer metastasis to bone and spine are not well understood. In this review the molecular mechanisms that may contribute to the highly metastatic phenotype of prostate cancer are discussed. Proangiogenic... Despite the clinical implication and high incidence of bone and spinal metastases, the molecular mechanisms behind prostate cancer metastasis to bone and spine are not well understood. In this review the molecular mechanisms that may contribute to the highly metastatic phenotype of prostate cancer are discussed. Proangiogenic factors such as vascular endothelial growth factor (VEGF) have been shown to not only aid in the metastatic capabilities of prostate cancer but also encourage the colonization and growth of prostate tumour cells in the skeleton. The importance of VEGF in the complex process of prostate cancer dissemination to the skeleton is discussed, including its role in the development of the bone premetastatic niche, metastatic tumour cell recognition of bone, and bone remodeling. The expression of VEGF has also been shown to be upregulated in prostate cancer and is associated with clinical stage, Gleason score, tumour stage, progression, metastasis, and survival. Due to the multifaceted effect VEGF has on tumour angiogenesis, tumour cell proliferation, and bone destruction, therapies targeting the VEGF pathways have shown promising clinical application and are being investigated in clinical trials. read more read less

Topics:

Prostate cancer (61%)61% related to the paper, Metastasis (60%)60% related to the paper, Vascular endothelial growth factor (56%)56% related to the paper, Bone remodeling (56%)56% related to the paper, Prostate (53%)53% related to the paper
View PDF
105 Citations
open accessOpen access Journal Article DOI: 10.1155/2012/327253
Castration-resistant prostate cancer: mechanisms, targets, and treatment.
Teresa Maria Santos Amaral1, Daniela Macedo, Isabel Fernandes1, Luis Costa1
05 Mar 2012 - Prostate Cancer

Abstract:

Patients with castration-resistant prostate cancer (CRPC), who progress after docetaxel therapy, had until very recently, only a few therapeutic options. Recent advances in this field brought about new perspectives in the treatment of this disease. Molecular, basic, and translational research has given us a better understandi... Patients with castration-resistant prostate cancer (CRPC), who progress after docetaxel therapy, had until very recently, only a few therapeutic options. Recent advances in this field brought about new perspectives in the treatment of this disease. Molecular, basic, and translational research has given us a better understanding on the mechanisms of CRPC. This great investment has turned into a more rational approach to the development of new drugs. Some of the new treatments are already available to our patients outside clinical trials and may include inhibitors of androgen biosynthesis; new chemotherapy agents; bone-targeted therapy; and immunotherapy. This paper aims to review the mechanisms of prostate cancer resistance, possible therapeutic targets, as well as new options to treat CRPC. read more read less

Topics:

Cabazitaxel (55%)55% related to the paper, Prostate cancer (54%)54% related to the paper, Enzalutamide (53%)53% related to the paper, Abiraterone acetate (51%)51% related to the paper
View PDF
101 Citations
open accessOpen access Journal Article DOI: 10.1155/2011/895238
Mouse Models of Prostate Cancer
Kenneth C. Valkenburg1, Bart O. Williams1
23 Feb 2011 - Prostate Cancer

Abstract:

The development and optimization of high-throughput screening methods has identified a multitude of genetic changes associated with human disease. The use of immunodeficient and genetically engineered mouse models that mimic the human disease has been crucial in validating the importance of these genetic pathways in prostate ... The development and optimization of high-throughput screening methods has identified a multitude of genetic changes associated with human disease. The use of immunodeficient and genetically engineered mouse models that mimic the human disease has been crucial in validating the importance of these genetic pathways in prostate cancer. These models provide a platform for finding novel therapies to treat human patients afflicted with prostate cancer as well as those who have debilitating bone metastases. In this paper, we focus on the historical development and phenotypic descriptions of mouse models used to study prostate cancer. We also comment on how closely each model recapitulates human prostate cancer. read more read less

Topics:

Prostate cancer (58%)58% related to the paper, Cancer (57%)57% related to the paper, Genetically Engineered Mouse (54%)54% related to the paper
View PDF
99 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Prostate Cancer.

It automatically formats your research paper to Hindawi formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Prostate Cancer format uses unsrt citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Prostate Cancer in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Prostate Cancer guidelines and auto format it.

2. Do you follow the Prostate Cancer guidelines?

Yes, the template is compliant with the Prostate Cancer guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Prostate Cancer?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Prostate Cancer citation style.

4. Can I use the Prostate Cancer templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Prostate Cancer.

5. Can I use a manuscript in Prostate Cancer that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Prostate Cancer that you can download at the end.

6. How long does it usually take you to format my papers in Prostate Cancer?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Prostate Cancer.

7. Where can I find the template for the Prostate Cancer?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Prostate Cancer's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Prostate Cancer's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Prostate Cancer an online tool or is there a desktop version?

SciSpace's Prostate Cancer is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Prostate Cancer?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Prostate Cancer?”

11. What is the output that I would get after using Prostate Cancer?

After writing your paper autoformatting in Prostate Cancer, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Prostate Cancer's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Prostate Cancer?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Prostate Cancer. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Prostate Cancer?

The 5 most common citation types in order of usage for Prostate Cancer are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Prostate Cancer?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Prostate Cancer's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Prostate Cancer in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Prostate Cancer Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Prostate Cancer formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template